
A New Hope for Heart Patients: The Impella Pump
In a remarkable development for patients undergoing high-risk cardiac procedures, the intervention cardiologists at VieCuri are now utilizing the Impella pump during dolterbehandelingen (angioplasties), which significantly reduces the need for patients to travel long distances to receive specialized care. This miniaturized heart pump plays a critical role during these procedure, which have historically been fraught with risks, including heart failure and sudden cardiac arrest.
What is the Impella Pump and How Does it Work?
The Impella pump, a small but powerful device capable of moving nearly four liters of blood per minute, is inserted via the patient's thigh. It temporarily takes over the heart's function, allowing medical staff to conduct potentially life-threatening procedures with greater security and control. According to Dr. Aydin, a cardiologist at VieCuri, the pump is crucial in instances where patients might experience dramatic drops in blood pressure or even cardiac arrest during treatment.
A Local Solution for a Serious Problem
Before this groundbreaking development, patients requiring the Impella pump had to travel to larger metropolitan hospitals in Maastricht or Eindhoven, placing an additional burden on them and their families. Now, thanks to collaborative efforts among intervention cardiologists, vascular surgeons, intensive care specialists, and radiologists, patients can receive this complex care right in Venlo, their home region.
Future Possibilities: Expanding the Use of Impella
While currently the Impella pump is planned for use in high-risk procedures alone, there is a vision to expand its application for other acute life-threatening heart issues. This expansion could provide timely interventions, potentially saving lives before patients can be transferred to a better-prepared facility.
Patient Experience: A Greater Sense of Agency
Notably, during the procedure, patients receive only local anesthesia, allowing them to stay awake and engaged. This aspect of care not only provides a level of comfort but can also empower patients, making them feel more in control during their treatment journey.
Understanding the Risks Associated with Angioplasty
Despite the many advancements, angioplasty still has risks. Approximately 1,200 people undergo this procedure at VieCuri annually, with about 12 classified as high-risk candidates for the Impella. This illustrates the importance of thorough patient evaluation and the careful selection of candidates who would benefit the most from this innovative technology.
Accessibility of Information for Patients
To ensure patients understand their treatment options fully, VieCuri offers informational brochures detailing the function and benefits of the Impella pump, as well as the angioplasty process.
In Summary: The introduction of the Impella pump at VieCuri represents a substantial leap forward in cardiac care for patients in the region. By minimizing travel and providing local support, this technology not only enhances medical intervention but also supports patient-centered care, placing a spotlight on the value of local access to state-of-the-art medical treatments.
Write A Comment